A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.

StatusRecruiting
PhasePhase 2/3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 4 more changesShow less
    • Start date changed from estimate of Sep 2026 to Sep 29, 2026
    • Secondary endpoints: details revised at 4 of 12 entries
    • Site details revised at 2 of 2 sites
    • Eligibility criteria shortened, about 3 words
  2. Start date: Jul 2026 to Sep 2026v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The study is being conducted to evaluate the efficacy and safety of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension. To explore the optimal use of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension。
Trial Details
NCT Number NCT07708441
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions
(from sponsor)		 Uncontrolled or Resistant Hypertension
Enrollment 914 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov